|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash | ||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Equity investment | ||||||||||||||
| Securities available for sale | ||||||||||||||
| Securities held to maturity (fair value of $5,083 and $5,102, ACL of $1 and $2) | ||||||||||||||
| Total loans | ||||||||||||||
| Allowance for credit losses | ||||||||||||||
| Net loans | ||||||||||||||
| Foreclosed real estate | ||||||||||||||
| Premises and equipment, net | ||||||||||||||
| Federal Home Loan Bank of Atlanta stock, at cost | ||||||||||||||
| Investment in life insurance | ||||||||||||||
| Accrued interest receivable | ||||||||||||||
| Goodwill | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Deferred tax assets, net | ||||||||||||||
| Other assets | ||||||||||||||
| Total assets | ||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||
| Liabilities | ||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||
| Interest-bearing deposits | ||||||||||||||
| Total deposits | ||||||||||||||
| FHLB borrowings | ||||||||||||||
| Subordinated debentures | ||||||||||||||
| Other liabilities | ||||||||||||||
| Total liabilities | ||||||||||||||
| Stockholders' equity | ||||||||||||||
| Preferred stock, $0.01 par value; 1,000,000 shares authorized; none issued or outstanding. | ||||||||||||||
| Common stock, $0.01 par value; 45,000,000 shares authorized at June 30, 2026 and December 31, 2025; 8,520,245 shares issued and outstanding as of June 30, 2026 and 8,852,813 issued and outstanding as of December 31, 2025 | ||||||||||||||
| Paid-in capital | ||||||||||||||
| Retained earnings | ||||||||||||||
| Unearned common stock held by employee stock ownership plan | ||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||
| Total stockholders' equity | ||||||||||||||
| Total liabilities and stockholders' equity |
Loading...
